A Clinical Study to Evaluate the Pharmacokinetics and the Absolute Bioavailability of SRT2104 Given as a 250mg Oral Suspension and Intravenous Microdose of 100 µg Carbon-14 Radio-labeled SRT2104 in Healthy Male Subjects
Clinical trial NCT00937872 · COMPLETED
Trial details
- NCT number
- NCT00937872
- Sponsor
- Sirtris, a GSK Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-22
- Primary completion
- 2008-12-22
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.